Rationale: Age and coronary artery disease may negatively affect the function of human cardiac stem cells (hCSCs) and their potential therapeutic efficacy for autologous cell transplantation in the failing heart.
S ubsequent to the recognition that hematopoietic stem cells may improve the outcome of myocardial infarction in animal models, 1 bone marrow mononuclear cells, CD34 ϩ cells, and mesenchymal stromal cells have been introduced clinically with rather consistent results. The intracoronary or intramyocardial injection of these cell classes has been shown to be safe and to produce a modest but significant enhancement in systolic function. 2 The identification of resident cardiac stem cells in the human heart, 3 together with the isolation of a complex pool of cardiac cells, namely, the cardiospheres, 4 has created great expectation concerning the potential implementation of these categories of autologous cells for the management of the human disease. Preclinical studies have been completed, and 2 phase 1 clinical trials are in progress in patients affected by acute (ClinicalTrials-.gov identifier: NCT00893360) and chronic (identifier: NCT00474461) ischemic cardiomyopathy. Although initial information is currently available on the efficacy of human cardiac stem cells (hCSCs), 5 the age of the patient and the type and duration of the disease may affect the number and growth properties of these primitive cells. Telomere attrition, cellular senescence, and apoptosis all contribute to decrease the com-partment of functionally competent hCSCs in the old failing heart. 6, 7 Because of the multiple variables that interfere with the growth behavior of stem cells in the aging decompensated heart, the objective of the present study was to define whether specific surface receptors can be used to distinguish hCSCs with high and low replicative reserve and ability to form myocytes and coronary vessels within the damaged myocardium. On the basis of clinical and animal data on aging and ischemic heart failure, 8, 9 the insulin-like growth factor (IGF) system and the renin-angiotensin system (RAS) were characterized in hCSCs to establish whether they can be used to distinguish pools of primitive cells with different therapeutic value for patients with ventricular dysfunction. Additionally, the effect of IGF-1, IGF-2, and angiotensin II (Ang II) on hCSC division, maturation, and death was determined. A series of in vitro and in vivo assays were performed to evaluate the independent and combined function of IGF-1 receptor (IGF-1R), IGF-2 receptor (IGF-2R), and angiotensin type 1 receptor (AT1R) and their respective ligands in hCSC growth and repair capacity.
Methods
Twenty-four human myocardial samples were used to isolate and expand hCSCs and define their in vitro properties. Distinct classes of hCSCs with low and high levels of cell growth were then injected in the infarcted heart to establish their differences in cardiac repair. Protocols are described in the expanded Methods section available in the Online Data Supplement at http://circres.ahajournals.org.
Results

Growth Factor Receptor Systems in hCSCs
Three complementary methodologies were used to document the presence of 3 growth factor receptor systems in c-kit ϩ hCSCs. IGF-1-IGF-1R, IGF-2-IGF-2R, and RAS were identified in these cells by quantitative reverse transcription-polymerase chain reaction, fluorescence-activated cell sorter (FACS) analysis, and immunocytochemistry. These protocols were introduced to exclude that protein products were derived from uptake of ligands from the circulation, which raises a question on the origin of IGF-1, IGF-2, and Ang II and the ability of hCSCs to synthesize these growth factors.
Transcripts for IGF-1, IGF-1R, IGF-2, IGF-2R, angiotensinogen, renin, angiotensin-converting enzyme, and AT1R were found in all cases, whereas AT2R mRNA was undetectable ( Figure 1A ; Online Figure I ). Importantly, IGF-1, IGF-1R, IGF-2, IGF-2R, AT1R, and AT2R proteins were present in hCSCs. These ligand and receptor epitopes were detected by FACS ( Figure 1B) , immunolabeling, and confocal microscopy ( Figure 1C ), as well as Western blotting ( Figure 1D ); however, angiotensin-converting enzyme was not detectable by Western blotting. ELISA was used to document the synthesis and secretion of IGF-1, IGF-2, and Ang II in hCSCs. For this purpose, these growth factors were measured in both hCSCs and culture medium ( Figure 1E ). The localization of angiotensinogen, renin, angiotensin-converting enzyme, and Ang II in the cytoplasm of hCSCs was established by confocal microscopy ( Figure 1F ).
The function of IGF-1 is largely mediated by binding to the receptor tyrosine kinase IGF-1R. 10 Alternative splicing occurs at the 5Ј and 3Ј ends of the Igf1 gene, which gives rise to several isoforms. All isoforms produce an identical mature form of IGF-1 that before secretion may undergo cleavage with release of the E peptide. 11 Although not all E peptides are cleaved before the secretion of IGF-1, it is generally believed that mature IGF-1 is the main mediator of the actions of IGF-1 through IGF-1R. 12 The Eb peptide fragments IBE1 and IBE2 are produced by IGF-1 class B isoforms and stimulate cell growth 11, 12 ; however, this E peptide extension is unique to the IGF-1 class B. For IGF-1 class A and class C, splicing results in a frame shift and a premature termination of translation. On the basis of quantitative reverse transcription-polymerase chain reaction, the predominant IGF-1 isoform in hCSCs and human myocardium was IGF-1A ( Figures 1G and 1H ). Thus, hCSCs possess 3 growth factor receptor systems that may have implications in defining the biological properties of these cells.
Age, Diabetes, and hCSCs
A cohort of 24 patients affected by chronic coronary artery disease were studied. These patients underwent elective bypass surgery for multivessel coronary atherosclerosis and largely preserved cardiac function. Age varied from 48 to 86 years, and both sexes were represented (10 women and 14 men). Type 2 diabetes mellitus was present in 7 women and 4 men and hypertension in 4 women and 10 men (Online Table I ). At surgery, the right atrial appendage was sampled, and c-kit ϩ hCSCs were isolated and propagated in vitro ( Figure  2A ). At passages 5 and 6, expanded hCSCs were characterized by FACS analysis. At these passages, 90Ϯ3% of hCSCs were c-kit ϩ and lineage negative. hCSCs did not express markers of hematopoietic stem cells and bone marrow-derived cells. Epitopes of mesenchymal stromal cells were also absent ( Figure  2B ). Transcription factors and cytoplasmic proteins specific for myocytes, smooth muscle cells, and endothelial cells were rarely observed ( Figure 2C ).
Aging was associated with changes in expression of IGF-1R, IGF-2R, and AT1R in hCSCs. The fraction of IGF-1R ϩ hCSCs decreased with age, whereas the proportion of IGF-2R ϩ and AT1R ϩ cells increased. A comparable impact of age was observed on the intracellular content of IGF-1, IGF-2, and Ang II ( Figure 2D ). Type 2 diabetes mellitus further increased the number of hCSCs that were positive for IGF-2R and AT1R. Sex differences did not result in changes in receptor and ligand expression (Online Figure II) . Our institutional review board precluded the acquisition of clinical data regarding the actual
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insulin-like growth factor-2 receptor mTOR mammalian target of rapamycin degree of ventricular dysfunction and the duration of coronary artery disease. Thus, aging upregulated the RAS and the IGF-2-IGF-2R axis and attenuated the IGF-1-IGF-1R pathway in hCSCs; diabetes had an additive negative effect on these parameters.
IGFs and hCSC Growth
To define the role of IGF-1R and IGF-2R in hCSCs, cells from 6 to 10 patients were selected randomly and studied further molecularly, biochemically, and functionally. These analyses included assessment of cell proliferation, differentia- Figure I ). B, Scatterplots of hCSCs; the stem cell antigen c-kit is expressed together with IGF-1, IGF-1R, IGF-2, IGF-2R, AT1R, and AT2R. Negative isotype control is also shown. C, Selected fields illustrating by immunolabeling and confocal microscopy that c-kit ϩ hCSCs (green) express IGF-1, IGF-1R, IGF-2, IGF-2R, AT1R, and AT2R. D, Expression of IGF-1R, IGF-2R, Aogen, renin, AT1R, and AT2R in hCSCs by Western blotting. GAPDH indicates loading conditions. E, Concentration of IGF-1, IGF-2, and Ang II by ELISA in culture medium (Medium) and hCSCs. F, Selected fields illustrating by immunolabeling and confocal microscopy that c-kit ϩ hCSCs express Aogen, renin, ACE, and Ang II. G, For the detection of IGF-1 isoforms, primers were designed between exons to avoid genomic DNA amplification. DNA sequences in the adjacent introns were examined to exclude binding of the primers to these regions. Primers 1F and 2F recognize class 1 and 2 isoforms, respectively. Primers AR, BR, and CR identify transcripts of classes A, B, and C. Primer 1ϭ2R is common for class 1 and tion, senescence, apoptosis, telomere-telomerase axis, and downstream effectors related to IGF-1R signaling. These in vitro assays were complemented with in vivo protocols. Autophosphorylation of IGF-1R leads to recruitment of the insulin receptor substrate protein (IRS) that upregulates PI3K and Akt. According to its cytoplasmic or nuclear localization, phospho-Akt favors cellular hypertrophy, differentiation, or proliferation. 13, 14 IGF-2 is the predominant form of IGF in humans; it binds to IGF-1R, IGF-2R, and the insulin receptor A isoform. 15 Binding of IGF-2 to IGF-2R promotes IGF-2 degradation and prevents its interaction with IGF-1R. 16 To determine the role of IGF-1R and IGF-2R in hCSC growth, cells that expressed only 1 of these 2 receptors or both of them were sorted by FACS ( Figure 3A ) and characterized ( Figure 3B ). Population doubling time was shorter in IGF-1R ϩ , longer in IGF-2R ϩ , and intermediate in IGF-1R ϩ -IGF-2R ϩ hCSCs ( Figure 3C ). Because population doubling time defines the growth kinetics of cells but does not assess the fraction of cycling cells, this variable was obtained by bromodeoxyuridine labeling; IGF-1R ϩ hCSCs showed levels of bromodeoxyuridine labeling higher than IGF-1R ϩ -IGF-2R ϩ and IGF-2R ϩ cells ( Figure 3D ). Long-term culture of IGF-1R ϩ hCSCs up to 20 passages did not result in alterations in the cell karyotype ( Figure 3E ). Additionally, the fraction of IGF-1R ϩ and IGF-2R ϩ hCSCs was preserved during their expansion in culture ( Figure 3F ).
Subsequently, the impact of each ligand, IGF-1 and IGF-2, on hCSC division was established. IGF-1 increased the proliferation of hCSCs that expressed IGF-1R alone or together with IGF-2R. IGF-2 had similar consequences but of smaller magnitude ( Figure 3G ). Conversely, both IGF-1 and IGF-2 failed to enhance the degree of bromodeoxyuridine labeling of IGF-2R ϩ hCSCs. To document that the growthpromoting effects of IGF-1 and IGF-2 on hCSCs were mediated by activation of IGF-1R, these protocols were repeated in the presence of IGF-1R-blocking antibody. Under this condition, hCSC division was largely inhibited ( Figure 3H ). Thus, IGF-1 and IGF-2 promoted hCSC division by activating IGF-1R, whereas IGF-2R had no influence on hCSC replication.
The differential response of IGF-1R ϩ -IGF-2R Ϫ hCSCs to IGF-1 and IGF-2 was characterized by the level and timing of phosphorylation of Akt at Ser473. This posttranslational modification was selected because its subcellular distribution in the cytoplasm and in the nucleus determines cellular division and hypertrophy, respectively. 13 IGF-1 and IGF-2 both stimulated IGF-1R, but the active state of the receptor was significantly higher and more prolonged in the presence of IGF-1 ( Figure 3I ). Importantly, nearly 10% of hCSCs exposed to IGF-1 and IGF-2 showed a nuclear localization of Akt at 10 minutes; however, at 1 hour, the fraction of Akt-labeled nuclei decreased markedly with IGF-2 and remained elevated with IGF-1 ( Figure 3J ).
IGFs and hCSC Differentiation
In several cell systems, IGF-1 and IGF-2 promote cell differentiation rather than cell proliferation. 10 Although these opposite processes of cell growth may be cell-context dependent, whether activation of IGF-1R by IGF-1 or IGF-2 exclusively regulates hCSC division or also induces the commitment of hCSCs to the myocyte lineage is presently unknown. Additionally, the response of hCSCs to IGFs may be time dependent; early activation of IGF-1R by IGF-1 or IGF-2 and cell multiplication ( Figure 3G ) may be followed by hCSC differentiation. The availability of hCSCs that were positive only for IGF-1R allowed us to precisely define the role of IGF-1R in these primitive cells.
Lineage-negative hCSCs were exposed to IGF-1 or IGF-2 for 12 and 36 hours, and the expression of GATA4, Nkx2.5, and ␣-sarcomeric actin (␣-SA) was determined by quantitative reverse transcription-polymerase chain reaction. After IGF-2 stimulation of IGF-1R ϩ hCSCs, the quantity of mRNA for GATA4, Nkx2.5, and ␣-SA did not change at 12 hours but increased at 36 hours. Similarly, transcripts of L-type Ca 2ϩ channels, Scn5A (␣-subunit of voltage-gated Naϩ channels type V), and ryanodine receptor increased from 12 to 24 hours. IGF-1 had smaller effects on hCSC differentiation at 24 hours ( Figure 4A ).
Changes at the protein level were evaluated at 12, 24, and 48 hours after exposure to IGF-1 or IGF-2. After IGF-2 stimulation, the percentage of IGF-1R ϩ hCSCs that expressed GATA4, Nkx2.5, and ␣-SA increased progressively from 12 to 24 and 48 hours. A comparable behavior was observed with respect to L-type Ca 2ϩ channels, Scn5A, and ryanodine receptor. Myofibrils with sarcomere striations were observed in the subsarcolemmal region ( Figures 4B and 4C ). FACS analysis at 48 hours confirmed the lineage specification of hCSCs ( Figure 4D ).
The impact of IGF-1 on IGF-1R ϩ hCSCs and myocyte commitment was less pronounced than that of IGF-2 and was mostly apparent at 48 hours; however, at that time point, there was a marked increase in the concentration of IGF-2 in the medium (Figure 4E) , mediated by the synthesis and secretion of this growth factor by activation of IGF-1R in hCSCs. Cardiomyocyte differentiation by IGF-1 or IGF-2 stimulation of hCSCs positive for both IGF-1R and IGF-2R or positive only for IGF-2R was rather modest (Online Figure III) .
The critical role of IGF-2 in the activation of IGF-1R and myocyte commitment of hCSCs was confirmed by the use of neutralizing IGF-1R antibody, which interfered with myocyte differentiation and largely preserved the primitive cell phenotype ( Figure 4F ). Thus, the transition from the replicative state to lineage specification of hCSCs appeared to involve the autocrine/paracrine release of IGF-2.
The impact of IGF-2 on the downstream effector of IGF-1R, mTOR, was determined by exposing hCSCs to IGF-2 in the presence of the mTOR inhibitor, rapamycin. Under this condition, the expression of genes that conditioned myocyte differentiation was markedly attenuated; they included Nkx2.5, GATA4, L-type Ca 2ϩ channels, ␣-SA, and Scn5A ( Figure 4G ).
IGFs and hCSC Death
Although the antiapoptotic effects of IGF-1 on cardiac stem cells have been documented repeatedly, 14 the role of IGF-2 in hCSC survival or death has not been defined. This is a relevant question in view of the importance of IGF-2 in the maturation of myocytes and the fact that this growth factor is the predominant form of IGFs in humans. 15 Ang II was used as a trigger for apoptotic cell death. 8 At baseline, apoptosis, measured by terminal deoxynucleotidyl transferase labeling, was modest and lower in IGF-1R ϩ hCSCs than in IGF-1R ϩ -IGF-2R ϩ and IGF-2R ϩ hCSCs. Exposure to Ang II at 10 Ϫ9 mol/L for a period of 12 hours increased apoptosis in all 3 hCSC categories but predominantly in IGF-2R ϩ and IGF-1R ϩ -IGF-2R ϩ hCSCs. The addition of IGF-1 attenuated cell death in IGF-1R ϩ and IGF-1R ϩ -IGF-2R ϩ cells ( Figures 5A through 5C ). Conversely, IGF-2 increased apoptosis in hCSCs that expressed IGF-2R alone or together with IGF-1R, which raises the possibility that IGF-2 and Ang II may have a synergistic effect on the activation of hCSC death. The differential response to Ang II of IGF-1R ϩ , IGF-2R ϩ , and IGF-1R-IGF-2R ϩ hCSCs reflected comparable differences in the expression of AT1R in these 3 stem cell classes, as measured by FACS analysis ( Figure 5D ). Moreover, to establish the specificity of IGF-2 in the induction of cell apoptosis, IGF-2R ϩ hCSCs were challenged with IGF-2 alone in the presence of IGF-2R-blocking antibody. Inhibition of IGF-2R function completely abrogated the apoptotic effect of IGF-2 ( Figure 5E ). Thus, activation of IGF-2R by IGF-2 initiated apoptosis, opposing the survival effects promoted by IGF-1. 
IGFs, RAS, and the Telomere-Telomerase Axis in hCSCs
The growth of stem cells is regulated by the length of their telomeres and the level of telomerase activity, which restores in part the telomere DNA lost after each cell division. 17 These 2 variables of stem cell expansion were measured in a subset of 12 patients from 48 to 86 years of age to define the replication growth reserve of hCSCs that expressed only IGF-1R, IGF-2R, or AT1R; these receptors characterize the role of IGFs and Ang II in hCSC function. This information was critical for recognition of the hCSC compartment that possessed the highest potential for myocardial regeneration in the diseased heart.
In all 12 cases, IGF-1R ϩ hCSCs had longer telomeres than IGF-2R ϩ cells; AT1R ϩ hCSCs had the shortest telomeres ( Figures 6A and 6B) . Surprisingly, a pool of hCSCs with essentially normal telomere length, 9 to 10 kilobase pairs, was present in the human heart at all ages. Therefore, aging resulted in an increase in the pool of hCSCs with short telomeres, ie, AT1R ϩ hCSCs, and a decrease in the pool of hCSCs with long telomeres, ie, IGF-1R ϩ hCSCs ( Figure 2D ). However, age did not deplete the compartment of highly functional resident stem cells, which suggests that the old heart retains a considerable growth reserve for cell turnover and tissue repair.
Measurements of telomerase activity in the 3 classes of hCSCs in each of the 12 cases showed comparable behavior ( Figure 6C ). IGF-1R ϩ hCSCs had the highest enzyme activity, whereas IGF-2R ϩ and AT1R ϩ hCSCs showed a reduced value, which confirms that IGF-1R ϩ hCSCs constitute the most pow- erful cell subset. This notion was consistent with the expression of the senescence-associated protein p16 INK4a in hCSCs; p16 INK4a expression was significantly higher in IGF-2R ϩ and AT1R ϩ hCSCs than in IGF-1R ϩ hCSCs ( Figure 6D ). Collectively, these findings suggest that a nonselected hCSC population should have a more limited regeneration potential than the restricted, highly enriched pool of IGF-1R ϩ hCSCs. Additionally, stimulation of IGF-1R ϩ hCSCs with IGF-2 may enhance their in vivo differentiation into mature cardiomyocytes, offering therapeutic options for the repair process of the infarcted heart.
Myocardial Regeneration After Infarction
To determine the therapeutic efficacy of unselected hCSCs, IGF-1R ϩ hCSCs (IGF-1R-hCSCs), and IGF-2 activated IGF-1R ϩ hCSCs (Ac-IGF-1R-hCSCs), cells were infected with a lentivirus carrying enhanced green fluorescent protein and delivered intramyocardially shortly after coronary artery ligation in immunosuppressed rats. Infarcted immunosuppressed rats injected with PBS were used as controls. IGF-2-stimulated IGF-2R ϩ cells were not included in this analysis in view of their limited growth capacity extensively characterized in vitro. Additionally, animals injected with PBS constituted the most appropriate negative control. At 10 days after surgery and cell delivery, large areas of tissue regeneration composed of newly formed enhanced green fluorescent protein-positive human myocytes and coronary vessels replaced the infarcted myocardium of the left ventricle (LV). Cardiac repair was not observed in untreated infarcts ( Figures 7A through 7D) , which suggests that myocyte and vessel formation in this group of animals was restricted to the surviving myocardium without invasion of the scarred region of the wall. 3, 18, 19 Infarct size, measured by the number of rat myocytes lost as a result of permanent coronary occlusion, involved nearly 70% of the cells of the free wall of the LV ( Figure 7E ). In all cases, the band of newly formed human tissue was distributed in the midportion of the infarct and only occasionally reached the epimyocardium or endomyocardium ( Figure 7D ). The human origin of the regenerated myocytes was confirmed by the detection of human DNA sequences with an Alu probe, together with the identification of human X chromosomes by quantitative fluorescence in situ hybridization and the expression of human troponin I ( Figures 7F through 7H) . Similarly, the regenerated human coronary arterioles and capillaries were Alu ϩ and carried human X chromosomes ( Figures 7I  and 7J ). In the 3 cell-treated infarcts, the newly formed packed myocytes occupied Ϸ84% of the regenerated tissue, whereas arterioles and capillaries accounted for Ϸ8% ( Figure  7K ). The specificity of the recorded signal for enhanced green fluorescent protein, ␣-SA, human troponin I, and Alu was validated by spectral analysis (Online Figure IV) .
The human myocardium comprised 7, 12, and 15 mm 3 of tissue after treatment with unselected hCSCs, IGF-1R-hCSCs, and Ac-IGF-1R-hCSCs, respectively ( Figure 8A) , which indicates that the unselected pool of hCSCs was associated with a smaller degree of tissue reconstitution. The increased recovery in myocardial mass in the other 2 cases resulted in attenuation of ventricular dilation and thinning of the wall in the spared and infarcted region of the LV. Additionally, wall thickness-to-chamber radius ratio and LV mass-to-chamber volume ratio were largely restored ( Figure 8B) .
Differences were found in the magnitude and characteristics of the human myocardium formed by IGF-1R-hCSCs and Ac-IGF-1R-hCSCs. The latter led to a 30% higher degree of tissue regeneration, which was the product of a 2.7-fold larger myocyte volume and a 40% lower myocyte number ( Figure  8C ). The prevailing hypertrophic response observed with Ac-IGF-1R-hCSCs was consistent with the in vitro findings and the lower level of myocyte replication measured by Ki67 in the regenerated myocardium ( Figure 8D ). Moreover, capillary length density per cubic millimeter of myocardium was higher in these hearts, which reflects a commensurate magnitude of vascularization dictated by the larger myocyte cross-sectional area ( Figure 8E) .
Treatment with IGF-1R-hCSCs and Ac-IGF-1R-hCSCs was coupled with reduced hypertrophy of spared rat myocytes ( Figure 8F ) and less negative LV remodeling ( Figure  8B) . Functionally, myocardial regeneration was characterized by the reappearance of contraction in the infarcted region of the LV and superior improvement in LV systolic pressure and positive and negative dP/dt ( Figure 8G ). Additionally, calculated diastolic wall stress was significantly decreased in these animals. Thus, IGF-1R ϩ hCSCs provided a re-markable recovery of the structure and function of the infarcted heart that was further enhanced by IGF-2 activation. Although similar changes in ventricular function were observed with IGF-1R-hCSCs and Ac-IGF-1R-hCSCs, the phenotypic properties of the regenerated cardiomyocytes differed with those protocols.
In summary, as illustrated schematically ( Figure 8H ), binding of IGF-1 and IGF-2 to IGF-1R activated the PI3K-Akt pathway that led to Akt phosphorylation at Ser473, which was more prolonged with IGF-1 than with IGF-2. Additionally, the presence of IGF-1R was coupled with enhanced telomerase activity and preservation of telomere integrity, which, in turn, favored hCSC division and survival. Commitment of hCSCs to the myocyte lineage involved the rapamycin-dependent and -independent mTOR signaling mechanisms that condition myocyte maturation. Conversely, binding of Ang II to AT1R and of IGF-2 to IGF-2R led to hCSC apoptosis, possibly mediated by protein kinase C phosphorylation of p53. 20 
Discussion
The results of the present study indicate that isolation and expansion of c-kit ϩ hCSCs from small samples of human myocardium yields a heterogeneous cell population composed of stem cell subsets with considerably different growth reserve in vitro and in vivo. The stem cell antigen c-kit is expressed in a population of hematopoietic stem cells that are capable of differentiating into cardiomyocytes and coronary vessels, in part replacing large myocardial infarcts with restoration of ventricular performance. 1 Similarly, the c-kit receptor tyrosine kinase identifies a pool of cardiac cells that reside in niches, 21 possess the properties of stem cells, and regenerate in vivo infarcted tissue with contracting myocardium. 3, 22 However, the present findings show that the association of c-kit with distinct proteins on the membrane of hCSCs conditions functional differences within an apparently uniform cell compartment. The behavior of hCSCs is dictated by a specific surface phenotype that permits the selective isolation of young, highly dividing hCSCs from the pool of c-kit ϩ cells. Different membrane receptors affect the phenotypic plasticity of hCSCs and their ability to compensate myocyte loss by forming new, efficiently contracting parenchymal cells.
Aging progressively decreases the compartment of hCSCs with high regenerative potential and progressively increases the pool of stem cells with minimal or no ability to divide and acquire cardiac cell lineages. The loss of hCSC function with aging is mediated in part by an imbalance between factors that promote growth and survival and factors that enhance oxidative stress, telomere attrition, and apoptosis. Three growth factor receptor systems appear to have a critical role in hCSC replication, differentiation, senescence, and death: IGF-1-IGF-1R, IGF-2-IGF-2R, and RAS. IGF-1-IGF-1R induces hCSC division, upregulates telomerase activity, maintains telomere length, hinders replicative senescence, and preserves the population of functionally competent cardiac stem cells in animals 23 and, as demonstrated here, in humans. The expression of IGF-1R and the synthesis of IGF-1 are attenuated in aging hCSCs, which possibly diminishes the ability of IGF-1 to activate cell proliferation and interfere with oxidative damage and telomeric shortening. 24 In progenitor cells, IGF-1 is generally linked to the protection of the primitive phenotype, 25 whereas IGF-2 induces the acquisition of the committed state, a phenomenon that has been identified in the present study in hCSCs. The presence of IGF-2 conditions the osteogenic differentiation of mesenchymal stromal cells 26 and the formation of skeletal myoblasts by satellite cells. 27 The function of IGF-1R ϩ hCSCs is regulated by both IGF-1 and IGF-2, which exert opposite effects on the fate of these cells. Importantly, cardiomyocytes and fibroblasts surrounding hCSCs have the ability to secrete the IGF-1 and IGF-2 ligand, 28, 29 which suggests that cross talk occurs within the cardiac niches where myocytes and fibroblasts function as supporting cells. 21, 30 These cells may dictate the developmental decision of hCSCs according to the needs of the organ. On the basis of the present data in humans and previous findings in animals, 8, 18, 19 IGF-1 may activate IGF-1R ϩ hCSCs, which possess high telomerase activity and rather intact telomeres, favoring their migration out of the niche area to regions of myocyte replacement. Defects in telomerase activity and telomere length oppose lodging and motility of progenitor cells in the skin 31 and in the heart. 8 Additionally, IGF-2, formed via an autocrine/paracrine mechanism, 32 may promote the transition of amplifying cells to a class of myocytes with a more mature phenotype, structurally and mechanically.
Consistent with these observations, skeletal muscle differentiation is strictly dependent on an autocrine loop initiated by the muscle secretion of IGF-2 that binds to IGF-1R in myoblasts. 33 This effector pathway targets transcriptional regulators of MyoD and the myogenin promoter. 34, 35 A similar mechanism appears to mediate cardiomyocyte differentiation, although the signaling cascade located downstream of IGF-1R in hCSCs remains to be determined. Thus, the recognition that hCSCs that express only IGF-1R synthesize both IGF-1 and IGF-2, which are potent modulators of stem cell replication, commitment to the myocyte lineage, and myocyte differentiation, points to this hCSC subset as the ideal candidate cell for the management of human heart failure.
The main function of IGF-2R is related to the clearance of IGF-2. Binding of IGF-2 to IGF-2R limits ligand bioavailability, which induces IGF-2 degradation and thereby prevents its interaction with IGF-1R. 16 In the present study, we have identified a novel function of IGF-2: Ligand binding to IGF-2R promotes apoptosis of hCSCs and enhances the effects of Ang II on cell death. The high level of expression of AT1R in IGF-2R ϩ hCSCs defines the surface phenotype of senescent cells, which are greatly prone to apoptotic death. Under conditions in which hCSC survival is essential for the well-being of the organ and organism, the upregulation of death genes appears to be a paradoxical response. However, preservation of the steady state may conform to an intrinsic mechanism aimed at the maintenance of a constant number of functionally competent hCSCs within the myocardial niches. Apoptosis of hCSCs may be regarded as a biological adaptation that removes unwanted old cells and concurrently triggers replication of young hCSCs and their commitment to the myocyte lineage.
IGFs are bound to IGF-binding proteins (IGFBPs), which modulate IGF ligand-receptor interactions and thereby their function. IGFBPs prolong the half-life of IGFs, but this process can result in the inhibition or stimulation of the IGF-1R and IGF-2R pathway. 36 Although the importance of IGFBPs is largely unknown, these proteins add a level of complexity to the study of IGFs. Recently, IGFBP-4 has been shown to enhance cardiomyocyte differentiation in vitro, whereas its deletion attenuates cardiomyogenesis in vitro and in vivo. 37 This role of IGFBP-4 is independent of its IGFbinding activity and is mediated by its direct interaction with Wnt receptors.
The documentation that a local RAS is present in hCSCs and that the formation of Ang II, together with the expression of AT1R, increases with age in hCSCs provides evidence in favor of the role of this octapeptide in hCSC senescence and death. Ang II may contribute to the age-dependent accumulation of oxidative damage in the heart. 38 Inhibition of Ang II positively interferes with heart failure and prolongs life in humans. 39 Ang II generates reactive oxygen species, and the most prominent form of DNA damage induced by free radicals is 8-OH-dG. In the presence of Ang II, 8-OH-dG increases more in old than in young progenitor cells. 8 8-OH-dG accumulates at the GGG triplets of telomeres, which results in telomeric shortening and uncapping. 40 Loss of telomere integrity is the major determinant of cellular senescence and death. Conversely, IGF-1 interferes with reactive oxygen species generation, 38 decreases oxidative stress with age, 23 and can repair DNA damage by homologous recombination. 41 Cardiac-restricted overexpression of IGF-1 delays the aging myopathy and the manifestations of heart failure in transgenic mice. 23 Thus, changes in the proportion of these growth factor receptor systems in hCSCs condition their growth reserve and potential therapeutic efficacy, a phenomenon documented here after infarction and the delivery of hCSC subsets.
In summary, the results of the present study suggest that the clinical implementation of autologous hCSCs in patients with acute and chronic ischemic cardiomyopathy necessitates a rather sophisticated approach that involves the characterization of the molecular signature of the cells to be delivered. Although extremely large numbers of different classes of bone marrow progenitor cells are currently being administered to patients, and hCSCs are now entering the scene of cell therapy for the decompensated heart, a careful analysis of the phenotypic properties of the cells to be used must be considered. The quality of the cells may be the critical factor for successful clinical outcome, rather than cell number.
